Drug intelligence / Profile preview

deproteinized calf blood extract

Development stage
Phase 3
Lead developer
Takeda
Modality
Recombinant Proteins and Enzymes, Peptides
Administration
Intravenous, Intramuscular, Topical, Ophthalmic
01

Overview

Deproteinized calf blood extract (DCBE) is a protein-free hemodialysate derived from the blood of veal calves through ultrafiltration. It contains a complex mixture of low molecular weight components, including amino acids, small peptides, and oligosaccharides. The drug acts as a metabolic enhancer by improving the transport and utilization of oxygen and glucose, thereby stimulating intracellular ATP synthesis and aerobic glycolysis. These effects are particularly beneficial under hypoxic or nutrient-deficient conditions, promoting tissue repair, regeneration, and neuroprotection. DCBE is utilized across various therapeutic areas: in ophthalmology as eye drops for dry eye disease and corneal epithelial repair; in neurology for post-stroke cognitive impairment and diabetic peripheral polyneuropathy; and in vascular medicine for peripheral arterial occlusive disease. While widely used in Russia, China, and Eastern Europe, its regulatory status and clinical evidence base vary internationally.

Brand names
ActoveginSolcoseryl
Other names
deproteinized calf blood hemodialysateprotein-free calf blood extractDCBE小牛血去蛋白提取物
02

Targets

GLUT9 (Glucose transporter type 9)

Beyond the preview

Go deeper on deproteinized calf blood extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on deproteinized calf blood extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call